表紙
市場調查報告書
商品編碼
1020685

智慧胰島素筆針的全球市場:現狀分析與未來預測 (2021年∼2027年)

Smart Insulin Pens Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 121 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球智慧胰島素筆針的市場規模,由於糖尿病患者增加和醫療費增加,各國政府的輔助策略,胰島素幫浦更高成本效率性等要素,大幅度擴大。智慧胰島素筆針,攜帶性高出門在外可簡單使用,及劑量可正確使用刻度盤設定(視覺障礙者也可操作) 等,有許多的優點。

各類型中第二世代急速成長,各終端用戶中居家醫療佔高佔有率。在各地區中,北美各國為最大市場。

本報告提供全球智慧胰島素筆針的市場相關分析,市場概要和背景情況、相關法規,市場基本結構和最新形勢,主要的促進、阻礙因素,整體市場規模趨勢預測,各類型、各利用形態、各終端用戶、各地區的詳細趨勢,市場競爭狀態,主要企業簡介等調查。

目錄

第1章 分析概要

第2章 分析方法與前提條件

第3章 市場概況

第4章 摘要整理

第5章 智慧胰島素筆針產業的主要的Start-Ups企業

第6章 新型冠狀病毒感染疾病 (COVID-19)的影響

第7章 全球智慧胰島素筆針市場收益趨勢

第8章 各種類的市場分析

  • 第一世代
  • 第二世代

第9章 各利用形態的市場分析

  • 預填充式
  • 再利用型

第10章 各終端用戶的市場分析

  • 醫院
  • 門診病人手術中心
  • 居家醫療

第11章 各地區的市場分析

  • 北美的智慧胰島素筆針市場
    • 美國
    • 加拿大
    • 其他的北美各國
  • 歐洲的智慧胰島素筆針市場
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他的歐洲各國
  • 亞太地區的智慧胰島素筆針市場
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他的亞太地區各國
  • 其他的國家 (RoW)的智慧胰島素筆針市場

第12章 智慧胰島素筆針的市場動態

  • 市場促進因素
  • 市場課題
  • 影響分析

第13章 法規、法律規範

第14章 需求與供給側面分析

  • 需求面分析
  • 供給側面分析
    • 主要的產品銷售的動向
    • 主要企業聯盟的動向
    • 主要的企業合併、收購 (M&A)的動向

第15章 價值鏈分析

第16章 智慧胰島素筆針的市場機會

第17章 智慧胰島素筆針市場趨勢與考察

第18章 競爭模式

  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 產業內的競爭情形
    • 替代品的可得性
    • 新加入業者的威脅

第19章 企業概要

  • Medtronics
    • 主要資料
    • 營業內容
    • 主要產品/服務
    • 成長策略
    • SWOT分析
    • 主要的財務指標
    • 目前的趨勢
  • Eli Lilly and Company
  • Novo Nordisk
  • Companion Medical, DIAMESCO
  • Emperra GmbH
  • Companion Medical
  • Ypsomed holding AG
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Snuza International

第20章 免責聲明

目錄
Product Code: UMHE21305

Smart insulin pens are used for external insulin delivery thus offering an easy to carry solution to diabetes management. The demand for the insulin pens has increased considerably in the recent years owing to the increase in incidence of diabetic patients coupled with their cost-effective nature as compared to insulin pumps.

Smart insulin pens offer several benefits as compared to other insulin delivery devices such as it is easier to use than syringe and being portable in nature, can be easily used outside home. In addition, the pen allows to dial the dose accurately, which helps the people with vision problems to administer insulin easily. Increasing prevalence of diabetes among the population, rising government initiatives and widening margins of healthcare spending are some of the factors significantly impacting the demand of smart diabetes management solutions. However, stringent government regulatory policies and long, tedious approval procedure, lack of healthcare infrastructure and unavailability of resources to support R&D work in poor countries has been restricting the growth of smart insulin pens market

Based on types, the market is fragmented into first generation and second-generation devices. The second-generation segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to its easy portability and wireless connectivity

Based on the end-users, the market is fragmented into hospitals, ambulatory surgery centers, and home care settings. The homecare settings segment on account of increasing geriatric population and rise self-administration among patients has generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027)

Based on the distribution channel, the market is fragmented into hospital pharmacy, online sales, retail pharmacy, and diabetes clinics/centres. The retail pharmacy segment generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027)

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Smart Insulin Pens industry and generated revenue of USD XX million in 2020 owing to the high prevalence for diabetes. The North American and Caribbean region spent some 325 billion U.S. dollars on health care for people with diabetes in 2019. However, the Asia Pacific region would grow at the highest CAGR during the forecast period due to its high population base and increase in incidence of diabetic patients

Some of the major players operating in the market include Eli Lilly and Company, Novo Nordisk, Companion Medical, DIAMESCO, Emperra GmbH, Companion Medical, Ypsomed holding AG, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co., Medtronics, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Global Smart Insulin Pens Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Global Smart Insulin Pens Market
    • 2.1.1 Main Objective of the Global Smart Insulin Pens Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER SMART INSULIN PENS INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL SMART INSULIN PENS MARKET REVENUE

8 MARKET INSIGHTS BY TYPE

  • 8.1 First Generation
  • 8.2 Second Generation

9 MARKET INSIGHTS BY USABILITY

  • 9.1 Pre-Filled
  • 9.2 Reusable

10 MARKET INSIGHTS BY END-USER

  • 10.1 Hospitals
  • 10.2 Ambulatory Surgery Centers
  • 10.3 Homecare Settings

11 MARKET INSIGHTS BY REGION

  • 11.1 NORTH AMERICA SMART INSULIN PENS MARKET
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Rest of North America
  • 11.2 EUROPE SMART INSULIN PENS MARKET
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 United Kingdom
    • 11.2.4 Spain
    • 11.2.5 Italy
    • 11.2.6 Rest of Europe
  • 11.3 ASIA PACIFIC SMART INSULIN PENS MARKET
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Australia
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia Pacific
  • 11.4 REST OF THE WORLD SMART INSULIN PENS MARKET

12 SMART INSULIN PENS MARKET DYNAMICS

  • 12.1 Market Drivers
  • 12.2 Market Challenges
  • 12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis
    • 14.2.1 Top Product Launches
    • 14.2.2 Top Business Partnerships
    • 14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 SMART INSULIN PENS MARKET OPPORTUNITIES

17 SMART INSULIN PENS MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1 Porter's Five forces analysis
    • 18.1.1 Bargaining power of Supplier
    • 18.1.2 Bargaining power of Buyer
    • 18.1.3 Industry Rivalry
    • 18.1.4 Availability of Substitute
    • 18.1.5 Threat of new Entrants

19 COMPANY PROFILED

  • 19.1 Medtronics
    • 19.1.1 Key Facts
    • 19.1.2 Business Description
    • 19.1.3 Key Product/Services Offerings
    • 19.1.4 Growth Strategy
    • 19.1.5 SWOT Analysis
    • 19.1.6 Key Financials
      • 19.1.6.1 Revenue Split
      • 19.1.6.2 Financial Overview of Medtronics
    • 19.1.7 Recent Developments
      • 19.1.7.1 Product Launch
      • 19.1.7.2 Partnerships
      • 19.1.7.3 Business Expansion and Investments
      • 19.1.7.4 Merger and Acquisition
  • 19.2 Eli Lilly and Company
  • 19.3 Novo Nordisk
  • 19.4 Companion Medical, DIAMESCO
  • 19.5 Emperra GmbH
  • 19.6 Companion Medical
  • 19.7 Ypsomed holding AG
  • 19.8 F. Hoffmann-La Roche AG
  • 19.9 Insulet Corporation
  • 19.10 Snuza International

20 DISCLAIMER